Navigation Links
NuVasive to Present at Goldman Sachs 29th Annual Global Healthcare Conference
Date:6/4/2008

phasizes both MAS and motion preservation.

NuVasive cautions you that statements included in this press release that are not a description of historical facts are forward-looking statements that involve risks, uncertainties, assumptions and other factors which, if they do not materialize or prove correct, could cause NuVasive's results to differ materially from historical results or those expressed or implied by such forward-looking statements. The potential risks and uncertainties that could cause actual growth and results to differ materially include, but are not limited to: the uncertain process of seeking regulatory approval or clearance for NuVasive's products or devices, including risks that such process could be significantly delayed; the possibility that the FDA may require significant changes to NuVasive's products or clinical studies; the risk that products may not perform as intended and may therefore not achieve commercial success; the risk that competitors may develop superior products or may have a greater market position enabling more successful commercialization; the risk that additional clinical data may call into question the benefits of NuVasive's products to patients, hospitals and surgeons; and other risks and uncertainties more fully described in NuVasive's press releases and periodic filings with the Securities and Exchange Commission. NuVasive's public filings with the Securities and Exchange Commission are available at http://www.sec.gov. NuVasive assumes no obligation to update any forward-looking statement to reflect events or circumstances arising after the date on which it was made.

Contact: Investors:

Kevin C. O'Boyle Nick Laudico/Zack Kubow

EVP & Chief Financial Officer The Ruth Group

NuVasive, Inc. 646-536-7030/7020


SOURCE NuVasive, Inc.
Copyright©2008 PR Newswire.
All rights reserved

0

GOOD

Page: 1 2 3

Related medicine news :

1. NuVasive to Present at ThinkEquity Partners 5th Annual Growth Conference
2. NuVasive Announces Web Cast and Conference Call of Third Quarter 2007 Results
3. NuVasive Licenses Its Insert and Rotate Technology
4. NuVasive Cancels 10/24/07 Investor Reception Due to Concerns Over Southern California Fires
5. NuVasive to Present at BIOCOM Investor Conference 2007
6. NuVasive Announces Preliminary Unaudited Full Year 2007 Financial Results
7. NuVasive to Offer $200 Million Convertible Senior Notes Due 2013
8. NuVasive Prices $200 Million Convertible Senior Notes Due 2013
9. NuVasive Reports First Quarter 2008 Financial Results
10. NuVasive Acquires First Stem Cell Bone Graft Substitute
11. AtriCure to Present at Thomas Weisel Partners 2007 Healthcare Conference
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:1/8/2009)...an. 8 Hanger Orthopedic ...that throughout the fourth quarter of 2008 it acqu...Rocky Mountain Orthotic-Prosthetics Center, Riesse...t Coast Orthotics & Prosthetics, and Orthopedi... add patient care centers to existing markets in M...
(Date:1/8/2009)..., Jan. 8 Medivation, Inc...ng, M.D., president and chief,executive officer, ...care,Conference on Wednesday, January 14, at 10:0...el in San Francisco. , Dr. Hung will provid...lopment programs for Dimebon for Alzheimer,s and H...
(Date:1/8/2009)...an. 8 A new educational...uidance on drugs, biological products and medical ...d Quality,s Centers for Education and Research on ...k of more than a dozen leading research centers na...Information Network ( CHAIN ) http://www.chainonl...
(Date:1/8/2009)...ed to Principal. Christine Siu and Jason Brown, P..., SAN FRANCISCO and STAMFORD, Conn., Jan. 8 /PRNew...h care venture capital firm that invests in life s...ounced the promotion of three members of its inves...ipal. Christine Siu and Jason Brown have been pro...
Breaking Medicine News(10 mins):Health News:Hanger Orthopedic Group, Inc. Announces Six Acquisitions Totaling $8.9 Million of Annual Net Revenue 2Health News:Medivation Announces Participation in 27th Annual J.P. Morgan Healthcare Conference 2Health News:AHRQ Announces New Web Site on Emerging Issues in Medical Therapeutics 2Health News:Thomas, McNerney & Partners Promotes Three Members of Its Investment Team 2
...stry of Health statistics it was shocking to find ...fered from breast cancer //. Out of the total numb...cases were Fijians, 22 were Indians and the rest b...s among the Fijians the Fiji Cancer Society's orga...
...ientist Iriti Marcello at the University of Milan ...ed wine have high levels of melatonin. The study r... food and Agriculture. This is a hormone which is ... mammals. But now the hormone’s existence in plant...
...Union Health Minister Ambumani Ramadoss demanding ... alleging he had instigated the institute's medico...des seeking Venugopal's removal, the delegation, c... doctors of the premier health institute, also dem...
...ntries to be worst hit by the bird flu, have confi... the disease //in Shanxi province on Monday. The ...at the outbreak was identified after an indefinite...rms in Changzi County. The officials have also men...
Other Medicine News:
(Date:1/6/2009)...ng a healthy immune system , , PURCHASE, N.Y., ...in Nutrition and Cancer (60(5), 643-651) by rese...an has shown that AHCC (Active Hexose Correlated C...e number of dendritic cells (DCs). DCs are a key p...g foreign substances to other immune system cells....
(Date:1/6/2009)... -- Pacira Pharmaceuticals, Inc., an,acute care s...hat enrollment,has been completed in two pivotal ...d efficacy of a single intraoperative administrati... postoperative analgesia. , Results from th...rthroplasty (TKA) are expected to provide the prim...
(Date:1/3/2009)...., Jan. 2 Magnetic reso...ing an increasing number of clinical benefits when...an article in the January 2009 issue of the Journa...( http://www.jaaos.org/ ). It is predicted that o...evelopments will allow MRI to provide even more us...
(Date:12/27/2008)..., offers to ease cloning costs for Clonaid clients...RNewswire-USNewswire/ -- Six years to the day afte...r. Brigitte Boisselier, head of the company that l...s cloned by her company are growing up healthy and... privacy. , , "We,ve helped almost 100 families...
Breaking Medicine Technology:Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 2Study Demonstrates that AHCC(R) Enhances Immune System by Increasing the Production of Key Dendritic Cells 3Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 2Phase III Studies of EXPAREL(TM) (DepoBupivacaine) from Pacira Complete Enrollment 3MRI Emerges As Vital Resource in Treatment of Back Pain 2MRI Emerges As Vital Resource in Treatment of Back Pain 3'We're Ready to Prove It!' 2Rosalind Franklin University of Medicine and Science First in Illinois to Equip Students With Computerized Diagnosis System 31928 1Rosalind Franklin University of Medicine and Science First in Illinois to Equip Students With Computerized Diagnosis System 31928 2Make a Mental Wellness New Years Resolution 3A How to Reduce Stress and Maintain Mental Health and Wellness in the Face of Economic Challenges 31926 1Make a Mental Wellness New Years Resolution 3A How to Reduce Stress and Maintain Mental Health and Wellness in the Face of Economic Challenges 31926 2Make a Mental Wellness New Years Resolution 3A How to Reduce Stress and Maintain Mental Health and Wellness in the Face of Economic Challenges 31926 3Rosetta Genomics Announces Commercial Availability of its First MicroRNA Based Diagnostic Test 3B Will Host Teleconference to Discuss Launch of Future 3613 1Rosetta Genomics Announces Commercial Availability of its First MicroRNA Based Diagnostic Test 3B Will Host Teleconference to Discuss Launch of Future 3613 2Rosetta Genomics Announces Commercial Availability of its First MicroRNA Based Diagnostic Test 3B Will Host Teleconference to Discuss Launch of Future 3613 3Rosetta Genomics Announces Commercial Availability of its First MicroRNA Based Diagnostic Test 3B Will Host Teleconference to Discuss Launch of Future 3613 4Rosetta Genomics Announces Commercial Availability of its First MicroRNA Based Diagnostic Test 3B Will Host Teleconference to Discuss Launch of Future 3613 5Danialle Karmanos Work It Out Names Tracey Secco as Director of Operations 31923 1Danialle Karmanos Work It Out Names Tracey Secco as Director of Operations 31923 2
Otoscope with 4X magnification lens, swivellable to both sides, with removable cover glass to insert external instruments. Sealed system allowing for pneumatic otoscopy. 2.7V vacuum lamp source.
Designed for instrumentation under magnification. Both lens and speculum can be swivelled. Open construction to allow access and examination under magnification and illumination.
Pocket-sized instrument with direct illumination. Avaliable in black, green or blue.
Pocket-sized instrument, powered by two AA-sized alkaline batteries. Built-in throat illuminator, rectangular viewing lens for instrumentation under magnification.
Medicine Products: